Aiforia Clinical HER2 Breast
Histopathology
breast
AI-assisted quantification of HER2 immunohistochemistry for breast cancer therapy selection.
Regulatory
| Regulatory status | Research Use |
| CE marked | Yes |
Research Use Only (RUO) — not for use in clinical diagnostic procedures.
Validation summary
Validation summary not yet populated. This entry currently lists only the regulatory pathway and headline citation; structured cohort and endpoint data are queued for v0.3.
| Study design | — |
| Cohort size | — |
| Number of validation sites | — |
| Site geography | — |
| Comparator | — |
| Primary endpoint | — |
| Primary result | — |
| External validation | — |
| Peer-reviewed | — |
| FDA decision summary | — |
Deployment
| Available | Yes |
Sources
- https://www.aiforia.com/ · company · 2026-04-20
How to cite this entry
Elbakri A. OncologyAI Registry: Aiforia Clinical HER2 Breast. Available at: https://oncologyairegistry.org/tools/aiforia-her2.html. Accessed [date].